Meyer L - Search Results

1

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, Pérez-Hoyos S, Jarrín I, Phillips A, Lodi S, van Sighem A, de Wolf W, Sabin C, Bansi L, Justice A, Goulet J, Miró JM, Ferrer E, Meyer L, Seng R, Toulomi G, Gargalianos P, Costagliola D, Abgrall S, Hernán MA; HIV-CAUSAL Collaboration. del Amo J, et al. Among authors: meyer l. Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460971 Free PMC article.

2

Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load.

Nakayama EE, Meyer L, Iwamoto A, Persoz A, Nagai Y, Rouzioux C, Delfraissy JF, Debre P, McIlroy D, Theodorou I, Shioda T; SEROCO Study Group. Nakayama EE, et al. Among authors: meyer l. J Infect Dis. 2002 Apr 15;185(8):1183-6. doi: 10.1086/339825. Epub 2002 Mar 20. J Infect Dis. 2002. PMID: 11930331

3

Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.

Harzic M, Pellegrin I, Deveau C, Chaix ML, Dubeaux B, Garrigue I, Ngo N, Rouzioux C, Goujard C, Hoen B, Sereni D, Delfraissy JF, Meyer L; PRIMO Study Group. Harzic M, et al. Among authors: meyer l. AIDS. 2002 Mar 29;16(5):793-6. doi: 10.1097/00002030-200203290-00017. AIDS. 2002. PMID: 11964538 No abstract available.

4

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.

Lacabaratz-Porret C, Urrutia A, Doisne JM, Goujard C, Deveau C, Dalod M, Meyer L, Rouzioux C, Delfraissy JF, Venet A, Sinet M. Lacabaratz-Porret C, et al. Among authors: meyer l. J Infect Dis. 2003 Mar 1;187(5):748-57. doi: 10.1086/368333. Epub 2003 Feb 18. J Infect Dis. 2003. PMID: 12599048 Clinical Trial.

5

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.

Chaix ML, Descamps D, Harzic M, Schneider V, Deveau C, Tamalet C, Pellegrin I, Izopet J, Ruffault A, Masquelier B, Meyer L, Rouzioux C, Brun-Vezinet F, Costagliola D. Chaix ML, et al. Among authors: meyer l. AIDS. 2003 Dec 5;17(18):2635-43. doi: 10.1097/00002030-200312050-00011. AIDS. 2003. PMID: 14685058

6

Does transient HAART during primary HIV-1 infection lower the virological set-point?

Desquilbet L, Goujard C, Rouzioux C, Sinet M, Deveau C, Chaix ML, Séréni D, Boufassa F, Delfraissy JF, Meyer L; PRIMO and SEROCO Study Groups. Desquilbet L, et al. Among authors: meyer l. AIDS. 2004 Dec 3;18(18):2361-9. AIDS. 2004. PMID: 15622312

7

Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?

Madec Y, Boufassa F, Rouzioux C, Delfraissy JF, Meyer L; SEROCO Study Group. Madec Y, et al. Among authors: meyer l. Clin Infect Dis. 2005 May 1;40(9):1350-4. doi: 10.1086/429318. Epub 2005 Mar 31. Clin Infect Dis. 2005. PMID: 15825038

8

Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, Bary M, Séréni D, Viard JP, Delfraissy JF, Meyer L; SEROCO Cohort Study Group. Rouzioux C, et al. Among authors: meyer l. J Infect Dis. 2005 Jul 1;192(1):46-55. doi: 10.1086/430610. Epub 2005 May 31. J Infect Dis. 2005. PMID: 15942893

9

Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection.

Kamga I, Kahi S, Develioglu L, Lichtner M, Marañón C, Deveau C, Meyer L, Goujard C, Lebon P, Sinet M, Hosmalin A. Kamga I, et al. Among authors: meyer l. J Infect Dis. 2005 Jul 15;192(2):303-10. doi: 10.1086/430931. Epub 2005 Jun 15. J Infect Dis. 2005. PMID: 15962225

10

Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.

Geskus RB, Meyer L, Hubert JB, Schuitemaker H, Berkhout B, Rouzioux C, Theodorou ID, Delfraissy JF, Prins M, Coutinho RA. Geskus RB, et al. Among authors: meyer l. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):321-6. doi: 10.1097/01.qai.0000142017.25897.06. J Acquir Immune Defic Syndr. 2005. PMID: 15980693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,233 results

Search Page